Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

156.20
-0.6200-0.40%
Post-market: 156.430.2300+0.15%19:59 EDT
Volume:8.41M
Turnover:1.32B
Market Cap:10.52B
PE:8.57
High:159.66
Open:158.27
Low:156.13
Close:156.82
52wk High:169.89
52wk Low:92.64
Shares:67.38M
Float Shares:67.38M
Volume Ratio:1.28
T/O Rate:12.49%
Dividend:0.56
Dividend Rate:0.36%
EPS(TTM):18.23
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Regis Healthcare Ltd. (REG) Receives a Buy from Macquarie

TIPRANKS
·
Sep 04

Health Care Flat on Rotation to Rate-Sensitive Sectors - Health Care Roundup

Dow Jones
·
Sep 04

Health Care Roundup: Market Talk

Dow Jones
·
Sep 04

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference

GlobeNewswire
·
Sep 04

PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference

GlobeNewswire
·
Sep 04

Alector to Participate in Upcoming Healthcare Conferences

GlobeNewswire
·
Sep 04

Xenon to Present at Wells Fargo Healthcare Conference

GlobeNewswire
·
Sep 04

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 04

Sector Update: Healthcare

MT Newswires Live
·
Sep 04

Analysts’ Top Healthcare Picks: Dogwood Therapeutics (DWTX), Quoin Pharmaceuticals (QNRX)

TIPRANKS
·
Sep 04

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live
·
Sep 04

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Sep 04

Health Care Roundup: Market Talk

Dow Jones
·
Sep 04

Analysts’ Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Sep 03

Spire Healthcare grants Toscafund brief extension on potential 250p-per-share bid

TIPRANKS
·
Sep 03

Sartorius Stedim Biotech Updates Share Capital and Voting Rights Structure

TIPRANKS
·
Sep 03

Analysts’ Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)

TIPRANKS
·
Sep 03

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

TIPRANKS
·
Sep 03

J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential

TIPRANKS
·
Sep 03

Press Release: PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business

Dow Jones
·
Sep 03